Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Oramed Pharmaceuticals Inc., an Israel-based drug developer, has announced that clinical trial for its oral insulin capsule has showed promising results.
The company said, Thursday, that the Phase 2a clinical trial for the ORMD-0801, the oral insulin capsule that it has developed has met safety goals. The weeklong study involved patients with type 2 diabetes and was conducted under a new U.S. Food and Drug Administration (FDA) drug protocol.
http://www.techtimes.com/articles/3...-clinical-trial-success-make-worlds-first.htm
So, a bit of clarification. It's intended for Type 2s in early stages of diagnosis, not as an MDI replacement.
The company said, Thursday, that the Phase 2a clinical trial for the ORMD-0801, the oral insulin capsule that it has developed has met safety goals. The weeklong study involved patients with type 2 diabetes and was conducted under a new U.S. Food and Drug Administration (FDA) drug protocol.
http://www.techtimes.com/articles/3...-clinical-trial-success-make-worlds-first.htm
So, a bit of clarification. It's intended for Type 2s in early stages of diagnosis, not as an MDI replacement.